stearic acid

stearic acid is a lipid of Fatty Acyls (FA) class. Stearic acid is associated with abnormalities such as Helminthiasis, Exanthema, Chronic disease, Obesity and Dyslipidemias. The involved functions are known as acyltransferase activity, Mutation, Cell division, cell fate and Fatty Acid Metabolism. Stearic acid often locates in membrane fraction, Mouse Liver, Membrane, Body tissue and Endoplasmic reticulum, membrane. The associated genes with stearic acid are Homologous Gene, ACLY gene, Transgenes, FATE1 gene and Alleles. The related lipids are Lysophospholipids, Stearic acid, Fatty Acids, cis-vaccenic acid and Phosphatidylserines. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of stearic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with stearic acid?

stearic acid is suspected in Obesity, Diabetes, Fatty Liver, Hyperinsulinism, Cardiovascular Diseases, Infection and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with stearic acid

MeSH term MeSH ID Detail
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Olfaction Disorders D000857 17 associated lipids
Acquired Immunodeficiency Syndrome D000163 12 associated lipids
Brain Edema D001929 20 associated lipids
Brain Diseases, Metabolic, Inborn D020739 10 associated lipids
Erectile Dysfunction D007172 19 associated lipids
Brain Ischemia D002545 89 associated lipids
Ischemia D007511 18 associated lipids
Seizures D012640 87 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with stearic acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with stearic acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with stearic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with stearic acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with stearic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with stearic acid?

Knock-out

Knock-out are used in the study 'Stearic acid accumulation in macrophages induces toll-like receptor 4/2-independent inflammation leading to endoplasmic reticulum stress-mediated apoptosis.' (Anderson EK et al., 2012) and Knock-out are used in the study 'Genome-wide association study identifies novel loci associated with concentrations of four plasma phospholipid fatty acids in the de novo lipogenesis pathway: results from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium.' (Wu JH et al., 2013).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with stearic acid

Download all related citations
Per page 10 20 50 100 | Total 3506
Authors Title Published Journal PubMed Link
Arida AI and Al-Tabakha MM Cellactose a co-processed excipient: a comparison study. 2008 Pharm Dev Technol pmid:18379907
Jójárt I et al. Study of the compressibility of chewing gum and its applicability as an oral drug delivery system. 2016 Pharm Dev Technol pmid:25673279
Patadia R et al. Investigating critical effects of variegated lubricants, glidants and hydrophilic additives on lag time of press coated ethylcellulose tablets. 2016 Pharm Dev Technol pmid:25566928
Kristó K et al. Effect of lubricant on spreading of coating liquid on surface of tablets containing pancreatin. 2010 Jul-Aug Pharm Dev Technol pmid:19772392
Wyttenbach N et al. Drug-excipient compatibility testing using a high-throughput approach and statistical design. 2005 Pharm Dev Technol pmid:16370179
Turkoglu M et al. Evaluation of hexagonal boron nitride as a new tablet lubricant. 2005 Pharm Dev Technol pmid:16176018
Mohanty B et al. Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery. 2015 Pharm Dev Technol pmid:24490828
Guadalupe Sánchez-González E et al. The influence of polymorphism on the manufacturability and in vitro dissolution of sulindac-containing hard gelatin capsules. 2015 Pharm Dev Technol pmid:24417644
Donoso M and Ghaly ES Prediction of tablets disintegration times using near-infrared diffuse reflectance spectroscopy as a nondestructive method. 2005 Pharm Dev Technol pmid:15926669
Ferrari F et al. Dissolution enhancement of an insoluble drug by physical mixture with a superdisintegrant: optimization with a simplex lattice design. 1996 Pharm Dev Technol pmid:9552342
Abdoh A et al. Amlodipine besylate-excipients interaction in solid dosage form. 2004 Pharm Dev Technol pmid:15000463
Otz M and Thoma H Effects of the metal type and the roughness of the die wall on the expended work for tablet ejection. 2000 Pharm Dev Technol pmid:10669914
Guo M and Augsburger LL Potential application of silicified microcrystalline cellulose in direct-fill formulations for automatic capsule-filling machines. 2003 Pharm Dev Technol pmid:12665197
von Eggelkraut-Gottanka SG et al. Roller compaction and tabletting of St. John's wort plant dry extract using a gap width and force controlled roller compactor. I. Granulation and tabletting of eight different extract batches. 2002 Pharm Dev Technol pmid:12503525
Uğurlu T and Halaçoğlu MD Effects of some lubricants and evaluation of compression parameters on directly compressible powders. 2014 Pharm Dev Technol pmid:23590449
Williams RO et al. Investigation of excipient type and level on drug release from controlled release tablets containing HPMC. 2002 Pharm Dev Technol pmid:12066573
El Hagrasy AS et al. Evaluation of risk and benefit in the implementation of near-infrared spectroscopy for monitoring of lubricant mixing. 2006 Pharm Dev Technol pmid:16895841
Badawy SI et al. Effect of spray-dried mannitol on the performance of microcrystalline cellulose-based wet granulated tablet formulation. 2010 Jul-Aug Pharm Dev Technol pmid:20088677
Ebube NK et al. Application of near-infrared spectroscopy for nondestructive analysis of Avicel powders and tablets. 1999 Pharm Dev Technol pmid:10027209
Donoso M et al. Prediction of tablet hardness and porosity using near-infrared diffuse reflectance spectroscopy as a nondestructive method. 2003 Pharm Dev Technol pmid:14601960
Hentzschel CM et al. Comparison of traditional and novel tableting excipients: physical and compaction properties. 2012 Nov-Dec Pharm Dev Technol pmid:21740091
Thosar SS et al. A comparison of reflectance and transmittance near-infrared spectroscopic techniques in determining drug content in intact tablets. 2001 Pharm Dev Technol pmid:11247272
Kushner J Utilizing quantitative certificate of analysis data to assess the amount of excipient lot-to-lot variability sampled during drug product development. 2013 Mar-Apr Pharm Dev Technol pmid:21877870
Taylor M and Elhissi AM Predicting the physical properties of tablets from ATR-FTIR spectra using partial least squares regression. 2011 Pharm Dev Technol pmid:20100067
Jelvehgari M et al. Formulation, characterization and in vitro evaluation of theophylline-loaded Eudragit RS 100 microspheres prepared by an emulsion-solvent diffusion/evaporation technique. 2011 Nov-Dec Pharm Dev Technol pmid:20722498
Likitlersuang S et al. The effect of binary mixture composition and magnesium stearate concentration on the Hiestand Tableting Indices and other related mechanical properties. 2007 Pharm Dev Technol pmid:17963153
Almeida IF et al. Moisturizing effect of oleogel/hydrogel mixtures. 2008 Pharm Dev Technol pmid:18720247
Badillo N and Ghaly ES In vitro evaluation of theophylline matrices using xyloglucan. 2008 Pharm Dev Technol pmid:18720251
Young PM et al. Effect of moisture on the compressibility and compactibility of sodium starch glycolate. 2007 Pharm Dev Technol pmid:17510894
van Kamp HV et al. Improvement by super disintegrants of the properties of tablets containing lactose, prepared by wet granulation. 1983 Pharm Weekbl Sci pmid:6622211
Bos CE et al. Native starch in tablet formulations: properties on compaction. 1987 Pharm Weekbl Sci pmid:3432037
Junginger HE Colloidal structures of O/W creams. 1984 Pharm Weekbl Sci pmid:6483570
Vehring R Pharmaceutical particle engineering via spray drying. 2008 Pharm. Res. pmid:18040761
Werle M Natural and synthetic polymers as inhibitors of drug efflux pumps. 2008 Pharm. Res. pmid:17896100
Parlati C et al. Pulmonary spray dried powders of tobramycin containing sodium stearate to improve aerosolization efficiency. 2009 Pharm. Res. pmid:19184617
Ménard N et al. Novel surfactants with diglutamic acid polar head group: drug solubilization and toxicity studies. 2012 Pharm. Res. pmid:22451248
Bolhuis GK et al. Hollow filler-binders as excipients for direct compaction. 2003 Pharm. Res. pmid:12669977
Kulinowski P et al. Magnetic resonance imaging and image analysis for assessment of HPMC matrix tablets structural evolution in USP Apparatus 4. 2011 Pharm. Res. pmid:21181545
Tuli RA et al. Studies on the effect of the size of polycaprolactone microspheres for the dispersion of salbutamol sulfate from dry powder inhaler formulations. 2012 Pharm. Res. pmid:22584947
John CT et al. Formulating weakly basic HCl salts: relative ability of common excipients to induce disproportionation and the unique deleterious effects of magnesium stearate. 2013 Pharm. Res. pmid:23512680
Govindarajan R et al. Ionization states in the microenvironment of solid dosage forms: effect of formulation variables and processing. 2006 Pharm. Res. pmid:16933092
Desrosiers Lachiver E et al. Insights into the role of electrostatic forces on the behavior of dry pharmaceutical particulate systems. 2006 Pharm. Res. pmid:16715390
Hsein H et al. Denatured Whey Protein Powder as a New Matrix Excipient: Design and Evaluation of Mucoadhesive Tablets for Sustained Drug Release Applications. 2017 Pharm. Res. pmid:28004316
Shilpi D et al. Improved Stability and Enhanced Oral Bioavailability of Atorvastatin Loaded Stearic Acid Modified Gelatin Nanoparticles. 2017 Pharm. Res. pmid:28466393
Cavallari C et al. Enhanced release of indomethacin from Pvp/stearic acid microcapsules prepared coupling Co-freeze-drying and ultrasound assisted spray-congealing process. 2007 Pharm. Res. pmid:17252191
Shimizu K et al. Characterization of tableting using the OSDRC system. 2007 Pharm. Res. pmid:17554609
Abbasi M et al. siRNA-mediated down-regulation of P-glycoprotein in a Xenograft tumor model in NOD-SCID mice. 2011 Pharm. Res. pmid:21638135
Bhope SG et al. Design and development of a stable polyherbal formulation based on the results of compatibility studies. 2011 Pharmacognosy Res pmid:21772756
Singhal A et al. Colon-targeted quercetin delivery using natural polymer to enhance its bioavailability. 2011 Pharmacognosy Res pmid:21731393
Ram HN et al. Formulation and evaluation of floating tablets of liquorice extract. 2010 Pharmacognosy Res pmid:21589757